146 Chapter 5 Implant (AMEI) in Children and Adolescents: Long-term, Multicenter Results. Otol Neurotol. 2019 Sep;40(8):1059-1067 29. Bruchhage KL, Leichtle A, Schönweiler R, Todt I, Baumgartner WD, Frenzel H, Wollenberg B. Systematic review to evaluate the safety, efficacy and economical outcomes of the Vibrant Soundbridge for the treatment of sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1797-1806 30. Lailach S, Zahnert T, Maurer J, Hempel JM, Koitschev A, Hollfelder D, Frenzel H, Wollenberg B, Arndt S. The vibrating ossicular prosthesis in children and adolescents: a retrospective study. Eur Arch Otorhinolaryngol. 2020 Jan;277(1):55-60 31. Takahashi M, Iwasaki S, Furutate S, Oka S, Oyamada S, Yasumura K. Active middle ear implant (vibrant soundbridge) in children with unilateral congenital aural atresia. Acta Otolaryngol. 2021 Jan;141(1):34-38 32. Frenzel H, Sprinzl G, Streitberger C, Stark T, Wollenberg B, Wolf-Magele A, Giarbini N, Strenger T, Müller J, Hempel JM. The Vibrant Soundbridge in Children and Adolescents: Preliminary European Multicenter Results. Otol Neurotol. 2015 Aug;36(7):1216-22 33. Leinung M, Zaretsky E, Lange BP, Hoffmann V, Stöver T, Hey C. Vibrant Soundbridge® in preschool children with unilateral aural atresia: acceptance and benefit. Eur Arch Otorhinolaryngol. 2017 Jan;274(1):159-165 34. https://www.gov.uk/government/news/cma-action-protects-outcomes-for-hearing-implantpatients
RkJQdWJsaXNoZXIy MTk4NDMw